For patienter ≥ 11 år skal den initiale dosis administereres subkutant eller intravenøst og udgøre 0, 45 µg/ kg kropsvægt.
For patients ≥ 11 years of age, the initial dose by subcutaneous or intravenous administration is 0.45 µg/ kg body weight, as a single injection once weekly.